- Report
- June 2022
- 174 Pages
Global
From €4918EUR$4,950USD£4,089GBP
- Report
- November 2021
- 263 Pages
Global
From €4918EUR$4,950USD£4,089GBP
- Report
- November 2023
- 76 Pages
Europe
From €1788EUR$1,800USD£1,487GBP
- Report
- November 2023
- 71 Pages
United States
From €1490EUR$1,500USD£1,239GBP
- Report
- October 2023
- 85 Pages
United States
From €4818EUR$4,850USD£4,006GBP
- Report
- August 2023
- 85 Pages
United States
From €4818EUR$4,850USD£4,006GBP
- Report
- July 2023
- 80 Pages
Global
From €4818EUR$4,850USD£4,006GBP
- Report
- November 2022
- 150 Pages
Global
From €4818EUR$4,850USD£4,006GBP
- Report
- August 2022
- 54 Pages
Global
From €2434EUR$2,450USD£2,024GBP
- Report
- November 2021
- 55 Pages
Europe
From €2434EUR$2,450USD£2,024GBP
- Report
- December 2020
- 34 Pages
Global
From €4918EUR$4,950USD£4,089GBP
- Report
- September 2023
- 76 Pages
Global
From €4918EUR$4,950USD£4,089GBP
- Report
- June 2023
- 69 Pages
Global
From €4918EUR$4,950USD£4,089GBP
- Report
- June 2023
- 65 Pages
Global
From €4918EUR$4,950USD£4,089GBP
- Report
- March 2023
- 60 Pages
Global
From €4918EUR$4,950USD£4,089GBP
- Report
- December 2022
- 77 Pages
Global
From €4918EUR$4,950USD£4,089GBP
- Report
- November 2022
- 74 Pages
Global
From €4918EUR$4,950USD£4,089GBP
- Report
- October 2022
- 71 Pages
Global
- Report
- February 2022
- 77 Pages
Global
From €2434EUR$2,450USD£2,024GBP
- Report
- December 2021
- 55 Pages
Global
The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more